Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection

Journal of Infectious Diseases

Volumn 195, Issue 2, 2007, Pages 288-295

  Coutinho, Hannah M ^a,b,c   Acosta, L P ^d   Wu, H W ^a   McGarvey, S T ^b   Su, L ^b   Langdon, G C ^a   Jiz, M A ^d   Jarilla, B ^d   Olveda, R M ^d   Friedman, J F ^a,c   Kurtis, J D ^a,c  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PRAZIQUANTEL; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CYTOKINE PRODUCTION; ECHOGRAPHY; FEMALE; HUMAN; HUMAN CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHILIPPINES; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; SCHOOL CHILD; SEX DIFFERENCE; TH2 CELL;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, HELMINTH; CHILD; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; LIVER CIRRHOSIS; LIVER DISEASES, PARASITIC; MALE; PARASITE EGG COUNT; PREVALENCE; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SEX FACTORS; TH2 CELLS;

EID: 33846137650     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/510313     Document Type: Article

References (42)

1. Newport G. Schistosomiasis. In: Warren K, ed. Immunology and molecular biology of parasitic infections. 3rd ed. Cambridge, MA: Blackwell Scientific Publications, 1993.
2. Mentink-Kane MM, Wynn TA. Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease. Immunol Rev 2004; 202:191-202.
3. Hoffmann KF, Wynn TA, Dunne DW. Cytokine-mediated host responses during schistosome infections: walking the fine line between immunological control and immunopathology. Adv Parasitol 2002; 52: 265-307.
4. H2 paradigm. Nat Rev Immunol 2004; 4:583-94.
5. Mohamed-Ali Q, Doehring-Schwerdtfeger E, Abdel-Rahim IM, et al. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel. Am J Trop Med Hyg 1991; 44:444-51.
6. Li YS, Sleigh AC, Li Y, et al. Five-year impact of repeated praziquantel treatment on subclinical morbidity due to Schistosoma japonicum in China. Trans R Soc Trop Med Hyg 2002;96:438-43.
7. Richter J. The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop 2003; 86:161-83.
8. Wiest PM, Wu G, Zhong S, et al. Impact of annual screening and chemotherapy with praziquantel on schistosomiasis japonica on Jishan Island, People's Republic of China. Am J Trop Med Hyg 1994; 51: 162-9.
9. de Jesus AR, Magalhaes A, Miranda DG, et al. Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun 2004; 72:3391-7.
10. Silva-Teixeira DN, Contigli C, Lambertucci JR, Serufo JC, Rodrigues V Jr. Gender-related cytokine patterns in sera of schistosomiasis patients with Symmers' fibrosis. Clin Diagn Lab Immunol 2004; 11:627-30.
11. Alves Oliveira LF, Moreno EC, Gazzinelli G, et al. Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans. Infect Immun 2006; 74:1215-21.
12. Booth M, Mwatha JK, Joseph S, et al. Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. J Immunol 2004; 172:1295-303.
13. Henri S, Chevillard C, Mergani A, et al. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol 2002; 169:929-36.
14. Dessein AJ, Hillaire D, Elwali NE, et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 1999; 65:709-21.
15. Wiest PM. The epidemiology of morbidity of schistosomiasis. Parasitol Today 1996; 12:215-20.
16. Mohamed-Ali Q, Elwali N-EMA, Abdelhameed AA, et al. Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. J Infect Dis 1999; 180:1298-306.
17. Marguerite M, Gallissot MC, Diagne M, et al. Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific cells. Trop Med Int Health 1999; 4:530-43.
18. Naus CW, Booth M, Jones FM, et al. The relationship between age, sex, egg-count and specific antibody responses against Schistosoma mansoni antigens in a Ugandan fishing community. Trop Med Int Health 2003; 8:561-8.
19. Klein SL. Hormonal and immunological mechanisms mediating sex differences in parasite infection. Parasite Immunol 2004; 26:247-64.
20. Twisk J, de Vente W. Attrition in longitudinal studies: how to deal with missing data. J Clin Epidemiol 2002; 55:329-37.
21. World Health Organization (WHO). Prevention and control of intestinal parasitic infections. WHO technical report series 749. Geneva: WHO, 1987:8-28.
22. Li YS, Kardorff R, Richter J, et al. Ultrasound organometry: the importance of body height adjusted normal ranges in assessing liver and spleen parameters among Chinese subjects with Schistosoma japonicum infection. Acta Trop 2004; 92:133-8.
23. Doehring-Schwerdtfeger E, Mohamed-Ali G, Abdel-Rahim IM, et al. Sonomorphological abnormalities in Sudanese children with Schistosoma mansoni infection: a proposed staging-system for field diagnosis of periportal fibrosis. Am J Trop Med Hyg 1989; 41:63-9.
24. Leenstra T, Acosta LP, Wu HW, et al. T-helper-2 cytokine responses to Sj97 predict resistance to reinfection with Schistosoma japonicum. Infect Immun 2006; 74:370-81.
25. Boros DL, Warren KS. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med 1970; 132:488-507.
26. Acosta LP, Waine G, Aligui GD, Tiu WU, Olveda RM, McManus DP. Immune correlate study on human Schistosoma japonicum in a well-defined population in Leyte, Philippines. II. Cellular immune responses to S. japonicum recombinant and native antigens. Acta Trop 2002; 84: 137-49.
27. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42:121-30.
28. Webster M, Libranda-Ramirez BD, Aligui GD, et al. The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma japonicum in human populations in Kenya and the Philippines. Parasitology 1997; 114(Pt 4):383-93.
29. Layland LE, Wagner H, da Costa CU. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice. Eur J Immunol 2005; 35:3248-57.
30. Mentink-Kane MM, Cheever AW, Thompson RW, et al. IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci USA 2004; 101: 586-90.
31. Curwen RS, Ashton PD, Johnston DA, Wilson RA. The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Mol Biochem Parasitol 2004; 138:57-66.
32. Olveda RM, Daniel BL, Ramirez BD, et al. Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity. J Infect Dis 1996; 174:163-72.
33. Li YS, Sleigh AC, Ross AG, et al. Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements. Trans R Soc Trop Med Hyg 2000; 94:191-7.
34. Vennervald BJ, Dunne DW. Morbidity in schistosomiasis: an update. Curr Opin Infect Dis 2004; 17:439-47.
35. Lansang MA. Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia. Gut 1996; 38(Suppl 2):S43-7.
36. Arguillas MO, Domingo EO, Tsuda F, Mayumi M, Suzuki H. Seroepidemiology of hepatitis C virus infection in the Philippines: a preliminary study and comparison with hepatitis B virus infection among blood donors, medical personnel, and patient groups in Davao, Philippines. Gastroenterol Jpn 1991; 26(Suppl 3):170-5.
37. Chevillard C, Moukoko CE, Elwali NE, et al. IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol 2003; 171:5596-601.
38. Hirayama K. Immunogenetic analysis of post-schistosomal liver fibrosis. Parasitol Int 2004; 53:193-6.
39. McManus DP, Ross AG, Williams GM, et al. HLA class II antigens positively and negatively associated with hepatosplenic schistosomiasis in a Chinese population. Int J Parasitol 2001; 31:674-80.
40. Al-Sherbiny M, Osman A, Barakat R, El Morshedy H, Bergquist R, Olds R. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop 2003; 88:117-30.
41. Medhat A, Shehata M, Bucci K, et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 1998; 178:512-9.
42. Dunne DW, Butterworth AE, Fulford AJ, et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992; 22:1483-94.